Time for better time-restricted eating trials to lessen the burden of metabolic diseases.
Pam R Taub, Satchidananda Panda
https://pubmed.ncbi.nlm.nih.gov/35732151Actively Recruiting
Led by University of California, San Diego · Updated on 2026-02-02
140
Participants Needed
1
Research Sites
26 weeks
Total Duration
U
University of California, San Diego
Lead Sponsor
S
Salk Institute for Biological Studies
Collaborating Sponsor
Researchers are studying the effects of time-restricted eating (TRE) on patients with metabolic syndrome who have high blood pressure and at least two other metabolic risk factors, such as increased waist size, abnormal cholesterol, high triglycerides, or elevated fasting glucose. The study focuses on people who typically eat for more than 12 hours daily and aims to better understand how limiting eating to a 10-hour window daily may impact cardiometabolic health over a long period. Participants are randomly assigned to one of two groups: one follows a daily 10-hour eating window combined with standard care and nutritional counseling, while the other continues their usual lifestyle without the eating window but also receives nutritional counseling. The study lasts 54 weeks and involves logging all food and drink intake using a smartphone app. Both groups receive lifestyle coaching and track their calories using the app. Throughout the study, researchers will measure height, weight, waist size, and blood pressure. Blood tests will check blood sugar control, insulin, lipids, and detailed cholesterol profiles. Participants will wear a continuous glucose monitor and an activity tracker at the start, six months, and the end of the study to monitor blood sugar, physical activity, and sleep. Body composition will be evaluated by DEXA scans, and an oral glucose tolerance test will assess how the body handles sugar. The main outcome is change in glucose levels after 54 weeks, along with other measures like cholesterol, insulin sensitivity, bone density, muscle mass, and body fat.
CONDITIONS
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 54 weeks
Participants follow a behavioral intervention where they either adhere to a daily, consistent 10-hour eating window with nutritional counseling or maintain their current lifestyle with nutritional counseling and track caloric intake using a smartphone app. They use the app throughout the study to log all food and beverage intake.
Regular meetings with a dietician and periodic assessments including blood tests, body measurements, and device wear at baseline, 6 months, and 12 months
Duration - Up to 12 months total from study start
Participants continue to be monitored for changes in cardiometabolic health parameters after the active intervention period.
Device-based monitoring with continuous glucose monitors and actigraphy devices worn for 2 weeks at baseline, 6 months, and 12 months
Total: 1 location
1
Altman Clinical and Translational Research Institute
La Jolla, California, United States, 92093
Actively Recruiting
G
Gavin McLaren
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Pam R Taub, Satchidananda Panda
https://pubmed.ncbi.nlm.nih.gov/35732151